|
Volumn 27, Issue 10, 2000, Pages 2339-2342
|
Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis
a a a |
Author keywords
Disease modifying antirheumatic drug; Endostatin; Rheumatoid arthritis; Vascular endothelial growth factor
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOGENIC FACTOR;
BASIC FIBROBLAST GROWTH FACTOR;
BUCILLAMINE;
ENDOSTATIN;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
VASCULOTROPIN;
ADULT;
ANGIOGENESIS;
ARTHRITIS;
ARTICLE;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SYNOVIAL FLUID;
SYNOVIOCYTE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
COLLAGEN;
CYSTEINE;
DRUG THERAPY, COMBINATION;
ENDOTHELIAL GROWTH FACTORS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FIBROBLAST GROWTH FACTOR 2;
HUMAN;
LYMPHOKINES;
MIDDLE AGE;
OSTEOARTHRITIS;
PEPTIDE FRAGMENTS;
PREDNISOLONE;
SULFASALAZINE;
SUPPORT, NON-U.S. GOV'T;
SYNOVIAL FLUID;
|
EID: 0033786484
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (88)
|
References (15)
|